Active, Not Recruiting
A Dose Escalation Study Evaluating CPI-818 in Relapsed/Refractory T-Cell Lymphoma
NCT03952078
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Stanford University Palo Alto, California, United States
- University of Michigan Ann Arbor, Michigan, United States
- Washington University St Louis, Missouri, United States
- Hackensack University Medical Center Hackensack, New Jersey, United States